Tue. 20 Feb 2024, 5:26pm ET
Benzinga
Earnings, News
GeneDx Hldgs (NASDAQ:WGS) reported quarterly losses of $(0.69) per share which beat the analyst consensus estimate of $(0.75) by 8 percent. This is a 97.62 percent increase over losses of $(29.04) per share from the same period last year. The company reported quarterly sales of $57.42 million which beat the analyst consensus estimate of $55.43 million by 3.59 percent. This is a 6.41 percent decrease over sales of $61.35 million the same period last year.